Exchange: NASDAQ·Updated 09:08 AM EDT
ARDX logo

ARDX Ardelyx Inc

$3.40
$0.0643
(1.93%)
Pre-Market
Prev Close $3.34
EarningsOct 29
Mkt Cap$832.29M
Vol1,633.00

About ARDX

Ardelyx, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs. Its products include IBSRELA and XPHOZAH. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.
44

Bearish Sentiment

How do you feel about ARDX?

Advertisement|Remove ads.